Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Polycystic Ovary Syndrome 3Obesity 1Lung Neoplasms 1Insulin Resistance 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Sodium-Glucose Transporter 2 Inhibitors × Clear all
NCT05966792 2026-04-13

SGLT2 Inhibitors in Treating Patients With PCOS

Shanghai 10th People's Hospital

Phase NA Completed
82 enrolled

Polycystic Ovary Syndrome

NCT07272057 2025-12-09

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

Shanghai Chest Hospital

Phase NA Not yet recruiting
200 enrolled
Thoracic

Lung Neoplasms

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed
68 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡